COVID-19 Pharmacological Management
Antipyretics

Antipyretics

Preferred Antipyretic

Acetaminophen 1g PO q6h

NSAIDs

There is a lack of evidence suggesting safety or harm in COVID-19 population

Avoid if evidence of acute kidney injury

Consider benefit vs harm:

  • Use the lowest effective dose for the shortest period of time to control fever due to COVID-19
  • NSAIDs should be used with caution in older people (over 60y) and those with underlying medical conditions since they are at higher risk of severe COVID-19